Last checked at 24 Oct 2011 09:51
24 October 2011
TRISTEL plc
Director Shareholding
Tristel plc ("Tristel" or the "Company"), the manufacturer of infection control, contamination control and hygiene consumable products, announces that Ms Elizabeth Dixon, Finance Director, has today acquired 2,000 ordinary shares of 1p each in the Company at 39.95p each.
Following this transaction Liz Dixon will be interested in 10,000 ordinary shares, representing 0.025% of the issued share capital of the Company.
For further information:
Tristel plc | Tel: 01638 721 500 | ||
Paul Swinney, Chief Executive Liz Dixon, Finance Director | |||
Walbrook PR Ltd | Tel: 020 7933 8780 | ||
Fiona Henson | Mob: 07886 335 992 or fiona.henson@walbrookpr.com | ||
Paul McManus | Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com | ||
FinnCap | |||
Geoff Nash / Charlotte Stranner (Corporate Finance) | Tel: 020 7600 1658 | ||
Simon Starr (Corporate Broking) |
| ||
About Tristel plc
Tristel plc is an infection prevention and contamination control business headquartered in Newmarket, United Kingdom. Its products are used to prevent hospital acquired infections, for hygiene in animal healthcare and by pharmaceutical and personal care manufacturers for contamination control. Its leading brands are Tristel (infection prevention) and Crystel (contamination control). The Group's products are considered to be amongst the highest performing biocides available to healthcare and industry. Tristel's lead technology is a proprietary chlorine dioxide formulation used to disinfect instruments and surfaces and to control legionella and biofilm build up in water.
Tristel was admitted to the London Stock Exchange AIM market in June 2005. Its stock exchange symbol is TSTL.